Ergocalciferols

"Ergocalciferols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24.

Descriptor ID	D004872
MeSH Number(s)	D04.210.500.247.222.474 D04.210.500.247.808.412 D04.210.500.812.768.462 D10.570.938.439
Concept/Terms	Ergocalciferols Ergocalciferols Calciferols Vitamin D 2 Vitamin D 2 Vitamin D2 D2, Vitamin Ergocalciferol

Below are MeSH descriptors whose meaning is more general than "Ergocalciferols".

Chemicals and Drugs [D]
Polycyclic Compounds [D04]
Fused-Ring Compounds [D04.210]
Steroids [D04.210.500]
Cholestanes [D04.210.500.247]
Cholestenes [D04.210.500.247.222]
Ergocalciferols [D04.210.500.247.222.474]
Sterols [D04.210.500.247.808]
Ergocalciferols [D04.210.500.247.808.412]
Secosteroids [D04.210.500.812]
Vitamin D [D04.210.500.812.768]
Ergocalciferols [D04.210.500.812.768.462]
Lipids [D10]
Membrane Lipids [D10.570]
Sterols [D10.570.938]
Ergocalciferols [D10.570.938.439]

Below are MeSH descriptors whose meaning is related to "Ergocalciferols".

Below are MeSH descriptors whose meaning is more specific than "Ergocalciferols".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Ergocalciferols" by people in this website by year, and whether "Ergocalciferols" was a major or minor topic of these publications.

Bar chart showing 6 publications over 6 distinct years, with a maximum of 1 publications in 2000 and 2001 and 2010 and 2011 and 2018 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2001	1	0	1
2010	0	1	1
2011	1	0	1
2018	0	1	1
2021	0	1	1

Below are the most recent publications written about "Ergocalciferols" by people in Profiles.

Wang B, Qian JY, Tang TT, Lin LL, Yu N, Guo HL, Ni WJ, Lv LL, Wen Y, Li ZL, Wu M, Cao JY, Liu BC. VDR/Atg3 Axis Regulates Slit Diaphragm to Tight Junction Transition via p62-Mediated Autophagy Pathway in Diabetic Nephropathy. Diabetes. 2021 11; 70(11):2639-2651.

View in: PubMed
Dai Q, Zhu X, Manson JE, Song Y, Li X, Franke AA, Costello RB, Rosanoff A, Nian H, Fan L, Murff H, Ness RM, Seidner DL, Yu C, Shrubsole MJ. Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial. Am J Clin Nutr. 2018 12 01; 108(6):1249-1258.

View in: PubMed
Halder SK, Sharan C, Al-Hendy O, Al-Hendy A. Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids. Reprod Sci. 2014 Sep; 21(9):1108-19.

View in: PubMed
Vera J, Gao LM, Santana A, Matta J, Mel?ndez E. Vectorized ferrocenes with estrogens and vitamin D2: synthesis, cytotoxic activity and docking studies. Dalton Trans. 2011 Oct 07; 40(37):9557-65.

View in: PubMed
Miller JE, Kovesdy CP, Norris KC, Mehrotra R, Nissenson AR, Kopple JD, Kalantar-Zadeh K. Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol. 2010; 32(5):403-13.

View in: PubMed
Maung HM, Elangovan L, Fraz?o JM, Bower JD, Kelley BJ, Acchiardo SR, Rodriguez HJ, Norris KC, Sigala JF, Rutkowski M, Robertson JA, Goodman WG, Levine BS, Chesney RW, Mazess RB, Kyllo DM, Douglass LL, Bishop CW, Coburn JW. Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison. Am J Kidney Dis. 2001 Mar; 37(3):532-43.

View in: PubMed
Fraz?o JM, Elangovan L, Maung HM, Chesney RW, Acchiardo SR, Bower JD, Kelley BJ, Rodriguez HJ, Norris KC, Robertson JA, Levine BS, Goodman WG, Gentile D, Mazess RB, Kyllo DM, Douglass LL, Bishop CW, Coburn JW. Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidism. Am J Kidney Dis. 2000 Sep; 36(3):550-61.

View in: PubMed

People

Explore

Similar Concepts

Top Journals